Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Haber

Showing results (281-290 of 322) with videos related to

Pageof 33
Sort By:
BMJ Open|November 13, 2019
Supporting Aboriginal Community Controlled Health Services to deliver alcohol care: protocol for a cluster randomised controlled trialKristie H Harrison, Ks Kylie Lee, Timothy Dobbins, et al.
Frontiers in Psychiatry|December 28, 2020
Genetic Polymorphisms on <i>OPRM1, DRD2, DRD4</i>, and <i>COMT</i> in Young Adults: Lack of Association With Alcohol ConsumptionPatrick Chung, Warren B Logge, Benjamin C Riordan, et al.
Neuropsychopharmacology Reports|October 23, 2025
The Effect of N-Acetylcysteine (NAC) on Neurometabolites and Cognitive Function in Adults With Alcohol Use Disorder: A Preliminary Randomized Controlled TrialKristiane Yacou Dunbar, Gezelle Dali, Marilena M DeMayo, et al.
Drug and Alcohol Review|February 19, 2026
Experiences of People Who Discontinue Long-Acting Injectable Buprenorphine Treatment Recently Released From Prison in New South Wales, AustraliaLucy J D Peck, Bethany White, Maja Moensted, et al.
The International Journal on Drug Policy|July 7, 2015
The effect of social functioning and living arrangement on treatment intent, specialist assessment and treatment uptake for hepatitis C virus infection among people with a history of injecting drug use: The ETHOS studyEmmanuel Fortier, Maryam Alavi, Michelle Micallef, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 26, 2025
FGF21 analogue PF-05231023 on alcohol consumption and neuronal activity in the nucleus accumbensBart J Cooley, Cassandra V Occelli Hanbury-Brown, Eun A Choi, et al.
Crisis|December 17, 2025
A Systematic Review and Meta-Analysis of Telehealth Aftercare Interventions to Reduce Suicidal Behavior or Suicide Following Hospital Treatment in the Emergency DepartmentEva Louie, Gregory Carter, Richard D Culter, et al.
The American Journal of Psychiatry|May 6, 2024
Topiramate Versus Naltrexone for Alcohol Use Disorder: A Genotype-Stratified Double-Blind Randomized Controlled TrialKirsten C Morley, Henry R Kranzler, Natasha Luquin, et al.
Journal of Gastroenterology and Hepatology|December 7, 2011
Effect of pegylated interferon-α-2a treatment on mental health during recent hepatitis C virus infectionMaryam Alavi, Jason Grebely, Gail V Matthews, et al.
Addiction (Abingdon, England)|October 10, 2015
Treatment for hepatitis C virus infection among people who inject drugs attending opioid substitution treatment and community health clinics: the ETHOS StudyJason Grebely, Maryam Alavi, Michelle Micallef, et al.
Pageof 33

Showing results (281-290 of 322) with videos related to

Sort By:
Pageof 33
BMJ Open|November 13, 2019
Supporting Aboriginal Community Controlled Health Services to deliver alcohol care: protocol for a cluster randomised controlled trialKristie H Harrison, Ks Kylie Lee, Timothy Dobbins, et al.
Frontiers in Psychiatry|December 28, 2020
Genetic Polymorphisms on <i>OPRM1, DRD2, DRD4</i>, and <i>COMT</i> in Young Adults: Lack of Association With Alcohol ConsumptionPatrick Chung, Warren B Logge, Benjamin C Riordan, et al.
Neuropsychopharmacology Reports|October 23, 2025
The Effect of N-Acetylcysteine (NAC) on Neurometabolites and Cognitive Function in Adults With Alcohol Use Disorder: A Preliminary Randomized Controlled TrialKristiane Yacou Dunbar, Gezelle Dali, Marilena M DeMayo, et al.
Drug and Alcohol Review|February 19, 2026
Experiences of People Who Discontinue Long-Acting Injectable Buprenorphine Treatment Recently Released From Prison in New South Wales, AustraliaLucy J D Peck, Bethany White, Maja Moensted, et al.
The International Journal on Drug Policy|July 7, 2015
The effect of social functioning and living arrangement on treatment intent, specialist assessment and treatment uptake for hepatitis C virus infection among people with a history of injecting drug use: The ETHOS studyEmmanuel Fortier, Maryam Alavi, Michelle Micallef, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 26, 2025
FGF21 analogue PF-05231023 on alcohol consumption and neuronal activity in the nucleus accumbensBart J Cooley, Cassandra V Occelli Hanbury-Brown, Eun A Choi, et al.
Crisis|December 17, 2025
A Systematic Review and Meta-Analysis of Telehealth Aftercare Interventions to Reduce Suicidal Behavior or Suicide Following Hospital Treatment in the Emergency DepartmentEva Louie, Gregory Carter, Richard D Culter, et al.
The American Journal of Psychiatry|May 6, 2024
Topiramate Versus Naltrexone for Alcohol Use Disorder: A Genotype-Stratified Double-Blind Randomized Controlled TrialKirsten C Morley, Henry R Kranzler, Natasha Luquin, et al.
Journal of Gastroenterology and Hepatology|December 7, 2011
Effect of pegylated interferon-α-2a treatment on mental health during recent hepatitis C virus infectionMaryam Alavi, Jason Grebely, Gail V Matthews, et al.
Addiction (Abingdon, England)|October 10, 2015
Treatment for hepatitis C virus infection among people who inject drugs attending opioid substitution treatment and community health clinics: the ETHOS StudyJason Grebely, Maryam Alavi, Michelle Micallef, et al.
Pageof 33